Rise Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-390
Closed -$221K 98
2025
Q4
$221K Sell
390
-8
-2% -$4.26K 0.08% 92
2025
Q3
$178K Buy
398
+44
+12% +$21.1K 0.06% 103
2025
Q2
$192K Sell
354
-24
-6% -$12.5K 0.08% 98
2025
Q1
$187K Buy
378
+20
+6% +$11.1K 0.08% 91
2024
Q4
$187K Buy
358
+3
+0.8% +$1.56K 0.09% 92
2024
Q3
$174K Sell
355
-8
-2% -$3.72K 0.08% 106
2024
Q2
$161K Sell
363
-2
-0.5% -$797 0.09% 107
2024
Q1
$146K Buy
365
+182
+99% +$68.8K 0.08% 112
2023
Q4
$61.7K Buy
183
+179
+4,475% +$53.4K 0.04% 136
2023
Q3
$1.17K Sell
4
-36
-90% -$11.2K ﹤0.01% 518
2023
Q2
$13.7K Sell
40
-27
-40% -$8.17K 0.01% 296
2023
Q1
$17.1K Hold
67
0.01% 276
2022
Q4
$17.8K Hold
67
0.01% 263
2022
Q3
$13K Hold
67
0.01% 295
2022
Q2
$13K Hold
67
0.01% 298
2022
Q1
$20K Buy
67
+4
+6% +$1.17K 0.02% 243
2021
Q4
$22.6K Buy
+63
New +$21.7K 0.02% 230

Other funds holding ISRG

Rise Advisors's ISRG Position: Q1 2026 in Review

Rise Advisors sold out of Intuitive Surgical (ISRG) in Q1 2026, closing a stake of 390 shares — an estimated $221K sold.

Rise Advisors first reported a position in ISRG in Q4 2021 and held it in 17 quarters. The position peaked at $221K in Q4 2025. 2,314 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Rise Advisors reported no remaining Intuitive Surgical position as of Q1 2026 after selling out during the quarter.
  • Rise Advisors sold 390 Intuitive Surgical shares in Q1 2026, an estimated $221K.
  • Rise Advisors first reported a position in Intuitive Surgical in Q4 2021 and held it in 17 quarters.
  • Rise Advisors's Intuitive Surgical position peaked at $221K in Q4 2025.
  • 2,314 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Rise Advisors's 13F filing for Q1 2026, filed 3 Apr 2026.